{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Andrejko KL"],"pubmed_abstract":["<h4>Background</h4>Despite lower circulation of influenza virus throughout 2020-2022 during the COVID-19 pandemic, seasonal influenza vaccination has remained a primary tool to reduce influenza-associated illness and death. The relationship between the decision to receive a COVID-19 vaccine and/or an influenza vaccine is not well understood.<h4>Methods</h4>We assessed predictors of receipt of 2021-2022 influenza vaccine in a secondary analysis of data from a case-control study enrolling individuals who received SARS-CoV-2 testing. We used mixed effects logistic regression to estimate factors associated with receipt of seasonal influenza vaccine. We also constructed multinomial adjusted marginal probability models of being vaccinated for COVID-19 only, seasonal influenza only, or both as co"],"journal":["Vaccine"],"pagination":["S0264-410X(22)01578-X"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9780637"],"repository":["biostudies-literature"],"pubmed_title":["Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season."],"pmcid":["PMC9780637"],"pubmed_authors":["Watt JP","Jain S","Andrejko KL","Myers JF","Li S","Lewnard JA","California COVID-19 Case-Control Study Team","Fukui N","Murray EL","Openshaw J","Pry JM","Hoover C"],"additional_accession":[]},"is_claimable":false,"name":"Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season.","description":"<h4>Background</h4>Despite lower circulation of influenza virus throughout 2020-2022 during the COVID-19 pandemic, seasonal influenza vaccination has remained a primary tool to reduce influenza-associated illness and death. The relationship between the decision to receive a COVID-19 vaccine and/or an influenza vaccine is not well understood.<h4>Methods</h4>We assessed predictors of receipt of 2021-2022 influenza vaccine in a secondary analysis of data from a case-control study enrolling individuals who received SARS-CoV-2 testing. We used mixed effects logistic regression to estimate factors associated with receipt of seasonal influenza vaccine. We also constructed multinomial adjusted marginal probability models of being vaccinated for COVID-19 only, seasonal influenza only, or both as co","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Dec","modification":"2025-04-04T08:25:14.544Z","creation":"2025-02-19T00:47:41.706Z"},"accession":"S-EPMC9780637","cross_references":{"pubmed":["36585281"],"doi":["10.1016/j.vaccine.2022.12.052"]}}